BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 7892130)

  • 1. Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases.
    Lafaye F; Rain JD; Clot P; Najean Y
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):359-62. PubMed ID: 7892130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
    Petroianu A
    Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenectomy for myelofibrosis.
    Järvinen H; Kivilaakso E; Ikkala E; Vuopio P; Hästbacka J
    Ann Clin Res; 1982 Apr; 14(2):66-71. PubMed ID: 7149614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of splenectomy in the treatment of myelofibrosis].
    Melikian AL; Kolosova LIu; Sokolova MA; Kovrigina AM; Silaev MA; Giliazitdinova EA; Gemdzhian ÉG; Karagiulian SR
    Ter Arkh; 2013; 85(8):69-76. PubMed ID: 24137967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenectomy for the massively enlarged spleen.
    Danforth DN; Fraker DL
    Am Surg; 1991 Feb; 57(2):108-13. PubMed ID: 1992865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Splenectomy in 5 patients with idiopathic myelofibrosis].
    Nozato A; Mizorogi F; Fukumi S; Watanabe H; Kobayashi M
    Rinsho Ketsueki; 2001 Aug; 42(8):627-32. PubMed ID: 11579502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
    Brenner B; Nagler A; Tatarsky I; Hashmonai M
    Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.
    Mesa RA; Nagorney DS; Schwager S; Allred J; Tefferi A
    Cancer; 2006 Jul; 107(2):361-70. PubMed ID: 16770787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Splenectomy for splenomegaly of more than 1000 grams. A retrospective study of 36 patients].
    Glehen O; Caillot JL; François Y; Peyrat P; Sadeghi Loyeeh B; Griot JB; Gilly FN; Vignal J
    Ann Chir; 1997; 51(10):1099-105. PubMed ID: 10868032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
    Ciurea SO; Sadegi B; Wilbur A; Alagiozian-Angelova V; Gaitonde S; Dobogai LC; Akard LP; Hoffman R; Rondelli D
    Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications after therapeutic splenectomy for hematologic disease in adults.
    Albrechtsen D; Ly B
    Acta Chir Scand; 1980; 146(8):577-81. PubMed ID: 7223297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenectomy for massive splenomegaly.
    Coon WW
    Surg Gynecol Obstet; 1989 Sep; 169(3):235-7. PubMed ID: 2772794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Splenectomy for massive splenomegaly. Apropos of 36 cases].
    Letoquart JP; Casa C; Grosbois B; Pompilio M; Haffaf Y; Leblay R; Mambrini A
    J Chir (Paris); 1990; 127(6-7):313-8. PubMed ID: 2211888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.
    Barosi G; Ambrosetti A; Buratti A; Finelli C; Liberato NL; Quaglini S; Ricetti MM; Visani G; Tura S; Ascari E
    Leukemia; 1993 Feb; 7(2):200-6. PubMed ID: 8426474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenectomy for agnogenic myeloid metaplasia.
    Coon WW; Liepman MK
    Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Splenectomy in immune thrombocytopenia and other hematological diseases].
    Lanzi S; Lancini GP; Piardi T; Biasca F; Ottaviani GM; Rossi G; Pizzoccaro C; Pouchè A
    G Chir; 1999; 20(11-12):479-86. PubMed ID: 10645065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
    Elliott MA; Tefferi A
    Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythroleukemia following erythropoietin therapy, extramedullary hematopoiesis, and splenectomy in a patient with myelofibrosis and myeloid metaplasia.
    Coleman TA; Hamill RL; Ford SM
    Am J Hematol; 2001 Jul; 67(3):214-5. PubMed ID: 11391725
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic splenectomy. Apropos of 38 cases].
    Letoquart JP; Casa C; Grosbois B; Pompilio M; Chaperon J; Lancien G; Jacomy D; Leblay R; Mambrini A
    Ann Chir; 1990; 44(5):342-7. PubMed ID: 2372195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Splenectomy in haematologic diseases. Clinical indications and surgical technique].
    Pugliese R; Maggioni D; Scandroglio I; Sansonna F; Grilloa G; Di Lernia S; Ferrari GC; Boniardi M; Costanzi A; Magistro C
    Chir Ital; 2005; 57(3):283-91. PubMed ID: 16231815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.